APOE genotype in cerebrovascular disease and vascular dementia. (Q53251385)

12 May 2018

title

APOE genotype in cerebrovascular disease and vascular dementia. (English)

1 reference

12 May 2018

main subject

dementia

0 references

cerebrovascular disease

1 reference

Frank A

1

1 reference

12 May 2018

Díez-Tejedor E

2

1 reference

12 May 2018

Bullido MJ

3

1 reference

12 May 2018

Valdivieso F

4

1 reference

12 May 2018

Barreiro P

5

1 reference

12 May 2018

publication date

1 November 2002

1 reference

12 May 2018

Journal of the Neurological Sciences

published in

1 reference

12 May 2018

volume

203-204

1 reference

12 May 2018

page(s)

173-176

1 reference

12 May 2018

Lipoprotein receptors: signaling functions in the brain?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

High apolipoprotein E epsilon 4 allele frequency in age-related memory decline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

The relationship between apolipoprotein E, dementia, and vascular illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

ApoE genotype and survival from intracerebral haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Analysis and interpretation of neuropsychologic tests in cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Severity of cardiovascular disease, apolipoprotein E genotype, and brain pathology in aging and dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Apolipoprotein E epsilon4 allele is a risk factor for late-onset Alzheimer's disease and vascular dementia in Han Chinese.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Association of apolipoprotein E E4 with vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: prevalence, plasma cholesterol levels and cerebrovascular change.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

The association between APOE and dementia does not seem to be mediated by vascular factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900286-1

10.1016/S0022-510X(02)00286-1

7 January 2021

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018